Overview

Antioxidant Treatment of Type 2 Diabetes

Status:
Completed
Trial end date:
2013-09-01
Target enrollment:
Participant gender:
Summary
This study examines whether an antioxidant taken orally will improve glucose tolerance and insulin secretion in type 2 diabetic subjects.
Phase:
Early Phase 1
Details
Lead Sponsor:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Treatments:
Antioxidants